Cannara Biotech Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 28, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Market Capitalization	175	165	61	90	118	149
Market Cap Growth	59.36%	168.86%	-32.29%	-23.64%	-20.54%	112.60%
Enterprise Value	187	198	105	131	146	160
Last Close Price	1.77	1.80	0.68	1.00	1.35	1.70
PE Ratio	16.28	12.59	9.51	13.02	51.35	-
PS Ratio	1.55	1.54	0.75	1.58	3.30	8.75
PB Ratio	1.45	1.61	0.70	1.13	1.77	2.32
P/TBV Ratio	1.45	1.61	0.70	1.13	1.77	2.32
P/FCF Ratio	10.85	12.05	19.05	-	-	-
P/OCF Ratio	6.33	8.22	5.73	15.29	-	-
EV/Sales Ratio	1.66	1.84	1.28	2.29	4.07	9.40
EV/EBITDA Ratio	7.73	7.04	7.62	7.92	16.91	58.11
EV/EBIT Ratio	10.50	9.13	13.69	11.17	30.25	3041.19
EV/FCF Ratio	11.62	14.47	32.55	-	-	-
Debt / Equity Ratio	0.28	0.41	0.55	0.57	0.73	0.33
Debt / EBITDA Ratio	1.41	1.47	3.45	2.75	5.54	7.15
Debt / FCF Ratio	2.12	3.05	15.04	-	-	-
Net Debt / Equity Ratio	0.10	0.27	0.47	0.52	0.54	0.20
Net Debt / EBITDA Ratio	0.52	0.97	3.04	2.51	4.21	4.63
Net Debt / FCF Ratio	0.77	1.99	12.98	-10.46	-1.68	-0.38
Asset Turnover	0.66	0.66	0.55	0.43	0.33	0.23
Inventory Turnover	1.31	1.32	1.41	1.14	1.40	1.39
Quick Ratio	1.15	0.83	0.73	0.70	1.75	1.63
Current Ratio	3.06	2.40	2.50	2.44	3.46	2.82
Return on Equity (ROE)	9.48%	13.75%	7.68%	9.48%	3.52%	-2.98%
Return on Assets (ROA)	6.49%	8.37%	3.23%	5.48%	2.77%	0.04%
Return on Invested Capital (ROIC)	9.10%	12.08%	6.09%	10.45%	5.36%	0.09%
Return on Capital Employed (ROCE)	11.70%	16.10%	6.00%	9.70%	4.20%	0.10%
Earnings Yield	5.81%	7.95%	10.52%	7.68%	1.95%	-1.03%
FCF Yield	9.22%	8.30%	5.25%	-4.39%	-18.20%	-22.26%
Buyback Yield / Dilution	-3.00%	-1.08%	-1.83%	-2.16%	-14.80%	-7.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.